DZ Bank raised its rating of AstraZeneca from neutral to buy on June 20, 2026.
1 report, 1 independent
Updated Jun 20
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
DZ Bank raised its rating of AstraZeneca from neutral to buy on June 20, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
DZ Bank
central institution for around 700 cooperative banks in Germany
-
AstraZeneca
British-Swedish pharmaceutical company
Related events
- DZ Bank upgraded American Express's financial rating on June 18, 2026.
- DZ Bank downgraded Frontline's stock rating on August 30, 2026.
- DZ Bank raised shares of American Express, which filed reports with the SEC, concurrent with Bank of America increasing its price target.
- DZ Bank, Royal Bank of Canada, and Jefferies Financial Group issued rating updates and began coverage on Leonardo stock.
- Citigroup, DZ Bank, and Berenberg Bank issued stock rating updates and research notes regarding Hugo Boss, headquartered in Metzingen.